# Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

> **NCT06070116** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 300 (estimated)

## Conditions studied

- Onchocercal Subcutaneous Nodule
- Onchocerciasis
- Onchocerciasis, Ocular
- Onchocerca Infection
- Tropical Disease

## Interventions

- **DRUG:** Ivermectin w/ Albendazole
- **DRUG:** Ivermectin + Diethylcarbamazine + Albendazole
- **DRUG:** Moxidectin + Albendazole
- **DRUG:** Moxidectin + Diethylcarbamazine + Albendazole

## Key facts

- **NCT ID:** NCT06070116
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-05
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06070116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06070116, "Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06070116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*